These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
764 related articles for article (PubMed ID: 15534053)
1. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. Choi JY; Jang HJ; Shim YM; Kim K; Lee KS; Lee KH; Choi Y; Choe YS; Kim BT J Nucl Med; 2004 Nov; 45(11):1843-50. PubMed ID: 15534053 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: comparison with positron emission tomography. Choi JY; Jang KT; Shim YM; Kim K; Ahn G; Lee KH; Choi Y; Choe YS; Kim BT Ann Surg Oncol; 2006 Aug; 13(8):1054-62. PubMed ID: 16865594 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma. Yasuda T; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Doki Y Ann Surg Oncol; 2015 Aug; 22(8):2599-607. PubMed ID: 25524011 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: a prospective study. Cheze-Le Rest C; Metges JP; Teyton P; Jestin-Le Tallec V; Lozac'h P; Volant A; Visvikis D Nucl Med Commun; 2008 Jul; 29(7):628-35. PubMed ID: 18528185 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of venous invasion and maximum standardized uptake value of Jeon JH; Lee JM; Moon DH; Yang HC; Kim MS; Lee GK; Zo JI Eur J Surg Oncol; 2017 Feb; 43(2):471-477. PubMed ID: 27912930 [TBL] [Abstract][Full Text] [Related]
8. Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer. Miyata H; Yamasaki M; Takahashi T; Murakami K; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y Br J Surg; 2013 Oct; 100(11):1490-7. PubMed ID: 24037571 [TBL] [Abstract][Full Text] [Related]
9. Impact of number of [(18)F]fluorodeoxyglucose-PET-positive lymph nodes on survival of patients receiving neoadjuvant chemotherapy and surgery for oesophageal cancer. Miyata H; Yamasaki M; Makino T; Tatsumi M; Miyazaki Y; Takahashi T; Kurokawa Y; Takiguchi S; Mori M; Doki Y Br J Surg; 2016 Jan; 103(1):97-104. PubMed ID: 26506079 [TBL] [Abstract][Full Text] [Related]
10. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma. Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884 [TBL] [Abstract][Full Text] [Related]
11. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer. Yap WK; Chang YC; Tseng CK; Hsieh CH; Chao YK; Su PJ; Hou MM; Yang CK; Pai PC; Lin CR; Hsieh CE; Wu YY; Hung TM Dis Esophagus; 2017 Aug; 30(8):1-10. PubMed ID: 28575243 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus. Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554 [TBL] [Abstract][Full Text] [Related]
13. The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma. Yasuda T; Higuchi I; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Hatazawa J; Doki Y Ann Surg Oncol; 2012 Feb; 19(2):652-60. PubMed ID: 21769466 [TBL] [Abstract][Full Text] [Related]
14. The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer. Kato H; Nakajima M; Sohda M; Tanaka N; Inose T; Miyazaki T; Fukuchi M; Oriuchi N; Endo K; Kuwano H Cancer; 2009 Jul; 115(14):3196-203. PubMed ID: 19472406 [TBL] [Abstract][Full Text] [Related]
15. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography. Yoo J; Choi JY; Moon SH; Bae DS; Park SB; Choe YS; Lee KH; Kim BT Int J Gynecol Cancer; 2012 Sep; 22(7):1226-33. PubMed ID: 22810970 [TBL] [Abstract][Full Text] [Related]
17. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108 [TBL] [Abstract][Full Text] [Related]
18. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1054-61. PubMed ID: 19101096 [TBL] [Abstract][Full Text] [Related]
19. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463 [TBL] [Abstract][Full Text] [Related]
20. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Konski AA; Cheng JD; Goldberg M; Li T; Maurer A; Yu JQ; Haluszka O; Scott W; Meropol NJ; Cohen SJ; Freedman G; Weiner LM Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):358-63. PubMed ID: 17532577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]